Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 15;13(2):157.
doi: 10.3390/cells13020157.

Alterations in Th17 Cells and Non-Classical Monocytes as a Signature of Subclinical Coronary Artery Atherosclerosis during ART-Treated HIV-1 Infection

Affiliations

Alterations in Th17 Cells and Non-Classical Monocytes as a Signature of Subclinical Coronary Artery Atherosclerosis during ART-Treated HIV-1 Infection

Tomas Raul Wiche Salinas et al. Cells. .

Abstract

Cardiovascular disease (CVD) remains an important comorbidity in people living with HIV-1 (PLWH) receiving antiretroviral therapy (ART). Our previous studies performed in the Canadian HIV/Aging Cohort Study (CHACS) (>40 years-old; Framingham Risk Score (FRS) > 5%) revealed a 2-3-fold increase in non-calcified coronary artery atherosclerosis (CAA) plaque burden, measured by computed tomography angiography scan (CTAScan) as the total (TPV) and low attenuated plaque volume (LAPV), in ART-treated PLWH (HIV+) versus uninfected controls (HIV-). In an effort to identify novel correlates of subclinical CAA, markers of intestinal damage (sCD14, LBP, FABP2); cell trafficking/inflammation (CCL20, CX3CL1, MIF, CCL25); subsets of Th17-polarized and regulatory (Tregs) CD4+ T-cells, classical/intermediate/non-classical monocytes, and myeloid/plasmacytoid dendritic cells were studied in relationship with HIV and TPV/LAPV status. The TPV detection/values coincided with higher plasma sCD14, FABP2, CCL20, MIF, CX3CL1, and triglyceride levels; lower Th17/Treg ratios; and classical monocyte expansion. Among HIV+, TPV+ versus TPV- exhibited lower Th17 frequencies, reduced Th17/Treg ratios, higher frequencies of non-classical CCR9lowHLADRhigh monocytes, and increased plasma fibrinogen levels. Finally, Th17/Treg ratios and non-classical CCR9lowHLADRhigh monocyte frequencies remained associated with TPV/LAPV after adjusting for FRS and HIV/ART duration in a logistic regression model. These findings point to Th17 paucity and non-classical monocyte abundance as novel immunological correlates of subclinical CAA that may fuel the CVD risk in ART-treated PLWH.

Keywords: HIV-1; Th17/Treg cells; antiretroviral therapy (ART); cardiovascular disease (CVD); myeloid/plasmacytoid dendritic cells; non-classical monocytes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Decreased Th17 frequencies and Th17/Treg ratios coincide with subclinical CAA in ART-treated PLWH. The frequencies of regulatory CD4+ T-cells (Tregs; CD25+FOXP3+CD127CD4+) (A), as well as Th17-polarized CD4+ T-cells (CCR6+CD26+CD161+) with memory (CD45RA), effector memory (EM) (CD45RACCR7), and central memory (CM) (CD45RACCR7+) phenotypes (B), were compared between TPV+ (n = 39) and TPV (n = 22) HIV+ participants. (C) Shown are the Th17/Treg ratios within the memory, EM, and CM Th17 subsets among TPV+ versus TPV HIV+ participants. Median and IQ range are indicated in red as horizontal lines. Differences among study groups were determined by Mann–Whitney rank test. p-values and statistical significance are indicated in the figures (*, p < 0.05; **, p < 0.01).
Figure 2
Figure 2
Non-classical CCR9lowHLA-DRhigh and M-DC8+HLA-DRhigh monocytes are expanded in ART-treated PLWH with subclinical CAA. Total monocytes (Mo) were identified as cells lacking the T-cell lineage markers CD3 and CD4 and the DC marker CD1c, and expressing HLA-DR (Supplemental Figure S7). Shown is the expression of CCR2, CX3CR1, CCR9, HLA-DR, and M-DC8 on classical (CD14++CD16) (A), intermediate (CD14++CD16+) (B), and non-classical (CD14+CD16++) Mo (C), as well as the expression of CCR2, CX3CR1, and HLA-DR on M-DC8+ Mo (D), in PBMCs of TPV+ (n = 39) versus TPV (n = 22) HIV+ participants. Median and IQ range are indicated in red as horizontal lines. Differences among study groups were determined by Mann–Whitney rank test. p-values and statistical significance are indicated in the figures (**, p < 0.01).

Similar articles

Cited by

References

    1. So-Armah K., Benjamin L.A., Bloomfield G.S., Feinstein M.J., Hsue P., Njuguna B., Freiberg M.S. HIV and cardiovascular disease. Lancet HIV. 2020;7:e279–e293. doi: 10.1016/S2352-3018(20)30036-9. - DOI - PMC - PubMed
    1. Wagle A., Goerlich E., Post W.S., Woldu B., Wu K.C., Hays A.G. HIV and Global Cardiovascular Health. Curr. Cardiol. Rep. 2022;24:1149–1157. doi: 10.1007/s11886-022-01741-1. - DOI - PubMed
    1. Kentoffio K., Temu T.M., Shakil S.S., Zanni M.V., Longenecker C.T. Cardiovascular disease risk in women living with HIV. Curr. Opin. HIV AIDS. 2022;17:270–278. doi: 10.1097/COH.0000000000000756. - DOI - PMC - PubMed
    1. Dirajlal-Fargo S., Funderburg N. HIV and cardiovascular disease: The role of inflammation. Curr. Opin. HIV AIDS. 2022;17:286–292. doi: 10.1097/COH.0000000000000755. - DOI - PMC - PubMed
    1. Boldeanu I., Sadouni M., Mansour S., Baril J.G., Trottier B., Soulez G., Chin S.A., Leipsic J., Tremblay C., Durand M., et al. Prevalence and Characterization of Subclinical Coronary Atherosclerotic Plaque with CT among Individuals with HIV: Results from the Canadian HIV and Aging Cohort Study. Radiology. 2021;299:571–580. doi: 10.1148/radiol.2021203297. - DOI - PubMed

Publication types

Substances